Quantinno Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Quantinno Capital Management's ACAD Position: Q3 2026 in Review
Quantinno Capital Management increased its Acadia Pharmaceuticals (ACAD) stake by 321% in Q3 2026, buying an estimated $1.84M and bringing the position to 89,978 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2271.
Quantinno Capital Management first reported a position in ACAD in Q3 2025 and has held it in 5 quarters since. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Quantinno Capital Management held 89,978 shares of Acadia Pharmaceuticals worth $1.81M as of Q3 2026.
- Quantinno Capital Management bought 68,607 Acadia Pharmaceuticals shares in Q3 2026, an estimated $1.84M.
- Acadia Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2271 holding.
- Quantinno Capital Management first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.